vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and PAMT CORP (PAMT). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $141.3M, roughly 1.9× PAMT CORP). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -20.7%, a 21.4% gap on every dollar of revenue. On growth, PAMT CORP posted the faster year-over-year revenue change (-15.1% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-25.0M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

HCM vs PAMT — Head-to-Head

Bigger by revenue
HCM
HCM
1.9× larger
HCM
$270.8M
$141.3M
PAMT
Growing faster (revenue YoY)
PAMT
PAMT
+1.4% gap
PAMT
-15.1%
-16.5%
HCM
Higher net margin
HCM
HCM
21.4% more per $
HCM
0.7%
-20.7%
PAMT
More free cash flow
HCM
HCM
$28.3M more FCF
HCM
$3.4M
$-25.0M
PAMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
PAMT
PAMT
Revenue
$270.8M
$141.3M
Net Profit
$2.0M
$-29.3M
Gross Margin
37.7%
Operating Margin
-13.2%
-27.0%
Net Margin
0.7%
-20.7%
Revenue YoY
-16.5%
-15.1%
Net Profit YoY
-83.6%
7.4%
EPS (diluted)
$0.00
$-1.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
PAMT
PAMT
Q4 25
$270.8M
$141.3M
Q3 25
$150.3M
Q2 25
$277.7M
$151.1M
Q1 25
$324.5M
$155.3M
Q4 24
$166.5M
Q3 24
$182.6M
Q2 24
$305.7M
$182.9M
Q1 24
$182.6M
Net Profit
HCM
HCM
PAMT
PAMT
Q4 25
$2.0M
$-29.3M
Q3 25
$-5.6M
Q2 25
$455.0M
$-9.6M
Q1 25
$11.9M
$-8.1M
Q4 24
$-31.6M
Q3 24
$2.4M
Q2 24
$25.8M
$-2.9M
Q1 24
$281.0K
Gross Margin
HCM
HCM
PAMT
PAMT
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
PAMT
PAMT
Q4 25
-13.2%
-27.0%
Q3 25
-3.8%
Q2 25
-1.3%
-7.3%
Q1 25
-5.0%
-5.9%
Q4 24
-22.6%
Q3 24
1.3%
Q2 24
-9.0%
-0.4%
Q1 24
-0.4%
Net Margin
HCM
HCM
PAMT
PAMT
Q4 25
0.7%
-20.7%
Q3 25
-3.7%
Q2 25
163.8%
-6.4%
Q1 25
3.7%
-5.2%
Q4 24
-19.0%
Q3 24
1.3%
Q2 24
8.4%
-1.6%
Q1 24
0.2%
EPS (diluted)
HCM
HCM
PAMT
PAMT
Q4 25
$0.00
$-1.38
Q3 25
$-0.27
Q2 25
$0.52
$-0.46
Q1 25
$0.01
$-0.37
Q4 24
$-1.44
Q3 24
$0.11
Q2 24
$0.03
$-0.13
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
PAMT
PAMT
Cash + ST InvestmentsLiquidity on hand
$1.4B
$83.7M
Total DebtLower is stronger
$93.2M
$333.9M
Stockholders' EquityBook value
$1.2B
$210.5M
Total Assets
$1.8B
$697.9M
Debt / EquityLower = less leverage
0.08×
1.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
PAMT
PAMT
Q4 25
$1.4B
$83.7M
Q3 25
$115.6M
Q2 25
$1.4B
$117.3M
Q1 25
$836.1M
$102.7M
Q4 24
$110.7M
Q3 24
$92.3M
Q2 24
$802.5M
$114.0M
Q1 24
$125.8M
Total Debt
HCM
HCM
PAMT
PAMT
Q4 25
$93.2M
$333.9M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
$325.6M
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
PAMT
PAMT
Q4 25
$1.2B
$210.5M
Q3 25
$239.5M
Q2 25
$1.2B
$244.9M
Q1 25
$759.9M
$269.6M
Q4 24
$277.5M
Q3 24
$308.9M
Q2 24
$740.1M
$306.7M
Q1 24
$314.6M
Total Assets
HCM
HCM
PAMT
PAMT
Q4 25
$1.8B
$697.9M
Q3 25
$715.2M
Q2 25
$1.8B
$707.9M
Q1 25
$1.3B
$712.6M
Q4 24
$741.7M
Q3 24
$756.7M
Q2 24
$1.3B
$733.5M
Q1 24
$746.4M
Debt / Equity
HCM
HCM
PAMT
PAMT
Q4 25
0.08×
1.59×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
1.17×
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
PAMT
PAMT
Operating Cash FlowLast quarter
$8.2M
$-5.8M
Free Cash FlowOCF − Capex
$3.4M
$-25.0M
FCF MarginFCF / Revenue
1.2%
-17.7%
Capex IntensityCapex / Revenue
1.8%
13.6%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$-23.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
PAMT
PAMT
Q4 25
$8.2M
$-5.8M
Q3 25
$5.9M
Q2 25
$-72.9M
$12.2M
Q1 25
$40.3M
$5.0M
Q4 24
$15.2M
Q3 24
$15.5M
Q2 24
$-39.8M
$18.7M
Q1 24
$9.6M
Free Cash Flow
HCM
HCM
PAMT
PAMT
Q4 25
$3.4M
$-25.0M
Q3 25
$2.5M
Q2 25
$-82.2M
$5.9M
Q1 25
$32.5M
$-6.8M
Q4 24
$-39.9M
Q3 24
$-33.6M
Q2 24
$-49.9M
$4.1M
Q1 24
$-12.2M
FCF Margin
HCM
HCM
PAMT
PAMT
Q4 25
1.2%
-17.7%
Q3 25
1.7%
Q2 25
-29.6%
3.9%
Q1 25
10.0%
-4.4%
Q4 24
-24.0%
Q3 24
-18.4%
Q2 24
-16.3%
2.2%
Q1 24
-6.7%
Capex Intensity
HCM
HCM
PAMT
PAMT
Q4 25
1.8%
13.6%
Q3 25
2.3%
Q2 25
3.3%
4.2%
Q1 25
2.4%
7.6%
Q4 24
33.1%
Q3 24
26.9%
Q2 24
3.3%
8.0%
Q1 24
12.0%
Cash Conversion
HCM
HCM
PAMT
PAMT
Q4 25
4.21×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
Q3 24
6.44×
Q2 24
-1.54×
Q1 24
34.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

PAMT
PAMT

Freight Transportation Service$123.1M87%
Fuel Surcharge$18.2M13%

Related Comparisons